The sensor for blood-flow need with neural activity and exercise is not known. We tested the hypothesis that accumulation of electrons in cytosolic free nicotinamide adenine dinucleotide (NAD) activates redox signaling pathways to augment blood flow. NAD is the primary carrier of electrons from glucose and lactate for ATP synthesis. Because increased glycolysis transfers electrons from glucose to NAD+ faster than they are used for mitochondrial ATP synthesis, electrons accumulate in cytosolic NADH. Because cytosolic NADH and intra-and extracellular lactate/pyruvate (L/P) ratios are all in near-equilibrium, NADH can be increased or decreased by i.v. lactate or pyruvate. Here, we report that elevated plasma LJ`P in non-nal rats increases blood flow in numerous resting tissues and augments blood flow increases in activated somatosensory (barrel) cortex and contracting skeletal muscle. Increased flows are largely prevented by injection of pyruvate (to lower L/P), a superoxide dismutase mimic (to block vascular effects of superoxide), or an inhibitor of nitric oxide synthase (to block *NO vasodilation). Electrons carried by. NADH, in addition to fueling ATP synthesis, also fuel redox signaling pathways to augment blood flow in resting and working tissues. These novel findings are fundamental to understanding blood-flow physiology and pathology.
glucose to cytosolic free NAD + ---reducing it to NADH---and the production of pyruvate exceed their use for mitochondrial ATP synthesis by oxidative phosphorylation (OP). Excess electrons and protons accumulating in NADH drive reduction of pyruvate to lactate coupled to oxidation of NADH to NAD + by lactate-dehydrogenase (DH) (Equation 1). This condition accounts for increased lactate production during aerobic work in brain and muscle (9) (10) (11) (12) (13) .
Observations in diabetic animals first suggested to us that accumulation of electrons in NADH might augment blood flow. Increased flows in tissues affected by diabetic complications are linked to accelerated flux of glucose via the sorbitol pathway. Specifically, the oxidation of sorbitol to fructose is coupled to transfer of electrons and protons from sorbitol to NAD' increasing NADH as with increased glycolysis. This redox change is independent of glycolysis, work, and oxygen tension (14) (15) (16) (17) ; both redox. change and increased blood flows are prevented by inhibitors of the sorbitol pathway. When ATP synthesis by OP is limited by availability of oxygen (i.e., hypoxia), glycolysis is increased to augment ATP synthesis by substrate phosphorylation (SP), electrons accumulate in NADH in the cytosol (as well as in mitochondria), and blood flow is increased (14, (17) (18) (19) (20) just as with aerobic work. We introduced the term "hyperglycemic pseudohypoxia" to emphasize similarities between effects of hyperglycemia and hypoxia on blood flow and accumulation of electrons in NADH (14) .
The coupling of increases in NADH and blood flow under such diverse metabolic and functional challenges as exercise, hyperglycernia, and hypoxia led to the hypothesis tested here: Accumulation of electrons in NADH signals blood-flow need and activates redox signaling pathways to augment flow.
MATERIALS AND METHODS

Strategy
Under steady-state conditions, near-equilibria exist between: 1) cytosolic-ftee NADH/NAD + and intracellular ( ic ) L/P ratios that are established by lactate-DH (L-DH) as shown in Equations I and 2, in which KL-DH = 1.11 x 10 -4 at pH 7.0 (21, 22) ; and 2) intracellular and extracellular( ec ) L/P ratios (Equation 3) that are established by monocarboxylate transporters (MCT) (23) .
Free cytosolic NADH and NAD + cannot be determined from measurements of NADH and NAD in whole tissue extracts that contain enzyme-bound as well as ftee cytosofic and mitochondrial NADH and NAD + . Also, enzyme-bound NAD is ~2 orders-of-magnitude more reduced than free NAD (21) . At present, free cytosolic NADH/NAD + can be evaluated only by the redox metabolite indicator method based on near-equilibria between the ratios of free NADH/NAD + and reduced/oxidized substrates of cytosolic dehydrogenase enzymes such as lactate-DH (Equations I and 2) (21)]. Here, NAD + (H) refers specifically to cytosolic free NAD + (H) VS. NAD + (H), which is enzyme-bound, and NAD + (H) in mitochondria.
Changes in pyruvate have a much greater impact than equimolar changes in lactate on L/P and NADH because the K m of L-DH is higher for lactate than for pyruvate; in resting tissues and plasma, lactate levels are ~10x higher than pyruvate. We assume that total cytosolic free NAD is unlikely to change substantially in these brief experiments so that increases in NADH/NAD + indicate increases in NADH, and the terms are used interchangeably. Therefore if the hypothesis is correct, injecting lactate to increase plasma L/P will increase L/P ic and drive reduction of NAD + to NADH (Equation 1), and increase NADH and blood flow; injection of pyruvate will have the opposite effect.
Paradigms
Regional blood flows were determined -in tissues at rest 5 min after intravenous (i.v.) bolus injections and after 5-14 continuous infusions of saline, lactate, and/or pyruvate. We evaluated direct effects of extravascular lactate levels on blood flow by applying lactate solutions to granulation tissue in skin wounds covered by plastic chambers where potential systemic effects of metabolites and pharmacological agents on tissue blood flow are obviated. Skeletal muscle contraction was evoked by electrical stimulation of the sciatic nerve in one hind limb. Increased neural activity in rat somatosensory cortex was evoked by contralateral whisker stimulation. Signaling pathways of blood-flow changes were evaluated in all paradigms.
Preliminary studies were performed to optimize protocols for injecting lactate and pyruvate in each paradigm. Plasma UP is rapidly normalized by the Cori cycle (8) 
Animals
We used male Sprague-Dawley rats. Housing, care, and all experimental protocols met Washington University and National Institutes of Health guidelines.
Blood flows
We assessed blood flows by using 11.3 µm. 46 Sc microspheres or 3 H-or 125 I-desmethylimipramine (DMI) (16, 27) . DMI, a plasma soluble tracer (M r = 266), was injected i.v.
Resting tissues
Rats were anesthetized with thiopental, and microspheres were injected 5 min after bolus injection of Na L-lactate (1 mmol/kg) and/or Na pyruvate (0.05 mmol/kg) or Na D-lactate (I mmol/kg) or after 5-h infusion of Na L-lactate (1.35 rnmol/kg/h) and/or Na pyruvate (0.027 mmol/kg/h). L-NAME was infused at 2.5 µmol/kg/min beginning 10 min before bolus lactate injection. Skin chamber granulation tissue was prepared 1 week before use (16) . Test substances in HEPES buffer (1.5 ml, pH 7.4) were added to chambers 20 min before assessment of blood flows with microspheres. Concentrations of test substances were 10 or 20 mM Na L-lactate, 10 mM Na D-lactate, 1 mM Na pyruvate, I mM EGTA, 0.05 mM Dantrolene, 1 mM L-NAME, 0.3 rnM SOD mimic , and 1000 U of catalase/ml.
Muscle stimulation
Rats were anesthetized with thiopental, and carmulae were placed in a subclavian artery to measure blood pressure and to obtain blood samples, a carotid artery for the withdrawal pump, and in both distal femoral veins for injection of tracers and for infusion of test substances. One sciatic nerve was stimulated in the sciatic notch at 10 Hz (10 V, 100 µs pulses).
3 H-or 125 I-DMI was injected I min before termination, and muscles were sampled for measurement of metabolites and blood flow.
Somatosensory cortex stimulation
Rats were anesthetized with urethane, and both iliac arteries and femoral veins were cannulated. One arterial cannula was used to monitor blood pressure and to obtain blood samples; the other, to measure blood flow. One femoral vein was used for injection of tracers; the other, for test substances. On one side of the face, ~20 whiskers were trimmed and fitted into a screen ˜ 8 mm from the skin attached to a mechanical device for rostrocaudal vibrissal deflection of 1.75 mm at 7.5 Hz (28). After 5 s of stimulation, 125 I-DMI was injected and the withdrawal pump was started. After 1 min, the great vessels were severed before we opened the skull and removed stimulated and unstimulated whisker barrel cortex (~3 mm in diameter and 1 rnm thick (29)), as well as olfactory bulbs and visual cortex. Cerebral blood flows with 125 I-DMI were comparable with flows with microspheres.
Metabolites
Lactate, pyruvate, and glucose were measured in extracts of arterial blood and muscle by standard enzymatic methods (15, 16) . NADH/NAD + was calculated by using Equation 2.
Statistics
Differences in parameters between animals are significant at P < 0.05, based on the general linear model procedure with SAS (16, 27) . Differences in parameters in the same rat were assessed by the paired t-test.
RESULTS
Resting tissues
Bolus injection or infusion of lactate increased blood flows in all tissues examined except heart and brain. Blood flows increased 50% in retina, 65% in sciatic nerve, 30% in epitrochlearis and gastrocnemius skeletal muscles, 86% in soleus muscle, and 40% in kidney. After lactate infusion for 5 h, blood-flow increases were 45% in retina, 2.4x in sciatic nerve, 3x in epitrochlearis muscle, 17% in diaphragm, and 77% in skin. Increased flows were prevented by injection of pyruvate with lactate; pyruvate alone did not affect flow. Bolus injection of D-lactate, which has the same isoelectric point as L-lactate, had no effect on regional blood flows. (This observation argues against a decrease in extracellular pH in mediating vasodilation by L-lactate.) Direct application of 10 or 20 MM L-lactate (but not D-lactate) trebled blood flows in skin chambers (P<0.0001). These increased flows were prevented when 1 mM pyruvate was coadministered with 20 mM lactate; pyruvate alone had no effect.
Plasma lactate levels doubled after 5 h of lactate infusion (from. 1.25 ± 0.46 to 2.61 ± 0.82 MM; mean ± SD), and blood pH increased (from 7.46 ± 0.05 to 7.54 ± 0.03). Coinfusion of pyruvate with lactate did not change plasma lactate levels or blood pH. Infusion of lactate with or without pyruvate did not affect mean arterial blood pressure (MAP; 127 ± 13 mmHg in controls). Lactate alone decreased peripheral vascular resistance and increased cardiac output by ~ 17% (P<0.05), reflecting widespread dilation -of resistance arterioles. These cardiovascular changes were completely prevented when pyruvate was coinfused with lactate.
Working muscle
Stimulation for 2 or 15 min increased blood flow in contracting adductor magnus, muscle 7x ( Fig.1A ) and in soleus muscle 3.5x. Infusion of lactate increased blood flows further in active muscle, whereas infusion of pyruvate decreased them (Fig.1A ) . Infusion of lactate or pymvate in this protocol did not affect blood flow to contralateral resting muscle. In contracting muscle, a strong positive relationship between blood flows and plasma L/P and a strong negative relationship to plasma lactate and pyruvate ( Fig. 1B and C) were found. Blood flow was unrelated to muscle L/P, lactate, or pyruvate (Fig, 1D . In contrast, blood flow in contralateral resting muscle was indifferent to plasma and muscle LP, lactate, or pyruvate (Fig,. 1B , C, and D).
Also, plasma L/P did not correlate with LP in resting muscle or contracting muscle (r 2 =0.04, P =0.4 for both muscles; Fig. 2 ). Specifically, muscle L/P was not increased by injection of lactate that increased blood flow. (This finding was confirmed in an independent experiment.)
Variation in lactate-evoked blood-flow changes in resting muscles with different protocols was related to differences in the total amount of lactate injected, the rate and duration of injection, and the time at which tissues were sampled during or following injection. Thus, blood flow in resting epitrochlearis was increased 73% at 1 min vs. 30% at 5 min after bolus injection of 1 mmol lactate/kg, and 3x after a 5-h infusion of lactate (1.35 mmol/kg/h). Resting soleus blood flow was increased 2x at 1 min vs. 86% at 5 min after bolus injection, but was unchanged by infusion,of I mmol lactate/kg over 15 min. Gastrocnernius flow was increased 2.5x at 1 min vs. 30% at 5 min after bolus injection. Plasma L/P ratios after bolus lactate injection (1 mmol/kg) were increased 3.5x at 20 s, 1.8x at 1 min, 1.4x at 2 min, 1.2x at 3 min, and back to normal at 5 min.
After 2 min of stimulation, contracting muscle L/P increased 11x, which reflected a 50% decrease in pyruvate and a 5x ,increase in lactate consistent with marked glycogenolysis. In muscle contracting for 15 min, L/P increased 16x as pyruvate levels fell by more than 85%, lactate levels did not change, and glucose levels tripled ( (Table I ) . (The increase in plasma lactate levels was identical to the Micrease after a 5-h lactate infusion in resting tissues.) Diffusion of lactate and pyruvate (at a high L/P ratio) from contracting muscle increases L/P in plasma from which lactate is taken up by the liver and other tissues and oxidized to pyruvate (8, 24) ; some pyruvate is used for gluconeogenesis by the Cori cycle and some diffuses back into plasma.
Worldng brain
Whisker stimulation increased blood flow 10.5% in contralateral vs. ipsilateral sornatosensory whisker barrel cortex (Fig. 3A) . Whisker stimulation did not change flow to visual and olfactory cortices. A lactate bolus injected I min before stimulation doubled the increase in blood flow evoked by whisker stimulation but had no effect on flow in resting barrel, visual, and olfactory cortices. Injection of pyruvate completely prevented whisker-stimulated flow increases without affecting flow to the unstimulated side (Fig.3A) . Lactate augmentation of blood flow in stimulated, but not in resting cortex, may be explained by a lactate-dependent increase in lactate transport between blood and brain (32) . As in working muscle, effects of lactate or pyruvate alone on brain blood flow were abrogated when they were coinjected. Likewise, blood flows to stimulated cortex paralleled increased plasma L/P ratios but not plasma lactate and pyruvate levels (Fig. 3B) , whereas flows in resting cortex were indifferent to plasma L/P, lactate, or pyruvate. In other experiments, visual stimulation increased blood flows in retina and visual cortex; these increased flows also were augmented by lactate, prevented by pyruvate, and strongly correlated with plasma L/Pratios (Ido et al., unpublished observations).
Hemodynamic, p1l, and electrolyte changes
Infusions for 15 min of lactate and pyruvate had no effect on blood pC0 2 , pO 2 , or MAP (Table 2) . However, blood pH was increased from 7.44 ± 0.02 (saline controls) to 7.49 ± 0.02 -7.51 ± 0.02 (P<0.02) with either 1 or 2 mmol pyruvate or 1 mmol lactate ± 2 mmol pyruvate. Lactate and/or pyruvate increased blood pH similarly yet evoked opposite changes in blood flow. These observations indicate that the opposite hemodynamic effects of lactate and pyruvate on peripheral resistance and blood flow are mediated by increases and decreases in NADH/NAD + , (by lactate and pyruvate, respectively) rather than by pH changes. This interpretation is consistent evidence that pH changes do not account for physiological work-induced increases in brain blood flow (9), lactate-induced relaxation of isolated rat mesenteric resistance arteries (33), or lactate-evoked reduction of tension development in working dog muscle (34) . release from endoplasmic reticulum) blocked lactate-augmented flows in granulation tissue. L-NAME prevented lactate-induced flows in granulation tissue and other resting tissues and blocked increased flow to stimulated somatosensory cortex without affecting flow to resting cortex (Fig.  3A) . L-NAME blocked increased blood flows to contracting muscle and reduced flow to contralateral. resting muscle by 50% (Fig. 1A ) L-NAME increased MAP from 107 ± 4 to 131 ± 9 in whisker stimulation experiments and from 136 ± 10 to 182 ± 6 in muscle stimulation experiments.
Nitric oxide
Increases in Ca
Superoxide
The SOD mimic prevented lactate-enhanced flow in granulation tissue and blocked increased flow in stimulated whisker cortex without affecting flow in resting cortex (Fig.3A) Catalase had no effect on lactate-induced flow increases in granulation tissue. The SOD mimic also reduced blood flow in contracting muscle by 67% but increased flow in resting muscle by 32% (Fig.1A) 
DISCUSSION
Observations in all experimental paradigms support the hypothesis that accumulation of electrons in NADH signals blood-flow need and regulates flow in resting and working tissues. The findings that blood flows in working muscle were strongly correlated with plasma, but not muscle L/P ( Fig   1B,C and D) , and that plasma and muscle L/P were not correlated suggest that blood-flow need can be sensed by accumulation of electrons in NADH within vascular cells per se. Thus, high ratios of L/P diffusing from contracting muscle cells (which are ~16x higher than in contralateral resting muscle and ~20x higher than in plasma (Table I ) increase interstitial L/P ec to increase L/P ic and NADH in vascular smooth muscle and endothelial cells (Equation 3 Fig. 4A ).
Similarly, elevation of plasma L/P ec (by lactate injection) and interstitial L/P ec (by addition of lactate to skin chambers) increases L/P ic and NADH in vascular cells. Studies of isolated vessels support this interpretation (33, (35) (36) (37) .
The strong correlation between blood flows and plasma L/P in contracting muscle, and the finding that both blood flow and plasma L/P ec were unrelated to muscle L/P, may be explained by the gradients of L/P ec and concentrations of lactate and pyruvate between plasma ec and L/P ic . in skeletal muscle cells. When lactate and pyravate are injected, L/P ec in plasma will be most affected. Interstitial L/P ec will be less affected as lactate and pyruvate diffuse across the vessel wall (between and through vascular cells) and mix with lactate and pyravate diffusing from skeletal muscle cells. L/P ic in vascular cells will be modulated by plasma L/P ec on one side and interstitial L/P ec on the other. Also, L/P ic in resting and contracting skeletal muscle cells will be least affected, if at all. This condition is because the concentration of lactate ic in contracting and resting muscle cells (and of pyruvate in resting muscle cells) is much higher than in plasma (Table 1) and will "buffer" effects of lactate and pyrtivate diffusing from plasma on L/P ic -NADH/NAD + . Thus, injection of lactate and pyruvate will impact more on L/P ic -NADH/NAD + in vascular endothelial cells and smooth muscle cells than in skeletal muscle cells.
Several studies in our laboratory indicate that increased blood flows induced by work and by lactate injection (Fig. 4A and B) are mediated by essentially the same redox signaling cascade that increases blood flows in resting tissues in response to elevated glucose levels in diabetes (14-17). The major difference is the source of electrons that activate the signaling cascade: glucose-derived sorbitol with diabetes, glucose-derived glyceraldehyde 3-phosphate (GA3P) with work, and lactate with lactate injection. In each case, electrons and protons are transferred to NAD + faster than they can be used by mitochondria for ATP synthesis. Electrons accumulating in NADH fuel redox signaling pathways that augment blood flow coupled to reoxidation of NADH to NAD + . Transfer of excess electrons from NADH to O 2 by NADHoxidase generates O 2 -(35), which elevates Ca 2+ i (14, 17, 38, 39) to activate 'NO production by cNOS. Excess electrons in NADH also favor de novo synthesis of diacylglycerol (14, 17) to activate PKC (protein kinase C)-mediated increased glucose transport in working muscle independent of insulin and hypoxia (40, 41) .
This signaling cascade is supported by: 1) observations that reactive oxygen species (H 2 O 2 , O 2 -) applied to the surface of the brain and to granulation tissue cause vasodilation and blood flow increases, which, in granulation tissue, are prevented by inhibitors of NOS (16, 42) ; and 2) most, but not all, reports that 'NO mediates increased blood flow in working skeletal muscle and somatosensory cortex (1, 2, 43, 44) . Increased blood flow in stimulated somatosensory cortex appears to be mediated largely by neuronal (n)NOS, because flow increases with whisker stimulation are blocked by NOS inhibitors in mice lacking endothelial (e)NOS (43) . In skeletal muscle, the cascade may be activated in contracting muscle cells that express nNOS and eNOS and in which both reactive oxygen species and 'NO increase during work (45, 46) . 'NO and O 2 could -then diffuse into vascular smooth muscle cells to cause vasodilation ( Fig. 4A and B) .
However, the finding that lactate injection increased blood flows in numerous resting tissues and in activated brain and muscle (without increasing muscle L/P) supports the likelihood that the signaling cascade can be initiated in vascular smooth muscle and/or endothelial cells by high ratios of L/P diffusing from plasma or skeletal muscle cells (Fig.4A) .
Lactate injection increased blood flows in resting tissues with widely differing metabolic profiles and functions. However, we found substantial differences in lactate-induced flow increases in different tissues at rest and between resting vs. stimulated skeletal muscle (Fig. I A) and whisker cortex (Fig. 3A) . Tissue differences in metabolism, MCT activity, capacity to reoxidize NADH to NAD + , and content of SOD, NOS and other factors all influence the signaling cascade for increasing blood flow. Collectively, these factors contribute to a tissue-specific "threshold!' below which elevated L/P ec ratios have little impact on L/P ic -NADH/NAD + and blood flow. This threshold is relatively high in heart (which is always working) and in resting brain in which blood flows were unaffected by lactate injection, intermediate in the diaphragm, and lower in a wide range of other tissues. Addition of lactate to the perfusate of isolated hearts increased myocardial NADH/NAD + ~5x without affecting coronary flow (47, 48) . Also, infusion of lactate to increase plasma L/P 2.6x did not increase coronary sinus blood flow in vivo (49) . Lactate infusion' does not increase cerebral blood flow in healthy subjects but augments regional flow elevations in individuals suffering from panic attacks (50) .
Cytosolic free NADH is positioned strategically to sense blood flow need. NAD + is the initial acceptor of electrons from glucose metabolites during glycolysis and from oxidation of lactate (Fig. 4A) . Electrons accumulate in NADH when: 1) they are transferred to NAD + at an increased rate coupled to oxidation of metabolites in the cytosol, and 2) increased mitochondrial free NADH impairs transfer of electrons from cytosolic NADH into mitochondria. Electrons accumulating in NADH then fuel redox signaling pathways that augment blood flow and reoxidize NADH to NAD + . Regardless of the cause of an increase in NADH, increased blood flow augments removal of lactate (accumulation of which limits glycolysis and ATP synthesis by SP) and delivery of oxygen to ensure maximal ATP synthesis-by OP. Also, increased delivery of blood with a low L/P ratio (in plasma and erythrocytes) promotes transfer of electrons and protons from NADH in vascular cells to pyruvate and facilitates their removal as lactate.
Sensing metabolic blood flow need by NADH complements the vital function of NAD as the principal and most efficient carrier of electrons from fuels for energy metabolism. ATP synthesis from glucose by substrate phosphorylation (SP) and OP is absolutely dependent on continuous redox cycling of NAD + ← → NADH (8), In hearts perfused with glucose, maximal glycolysis is the same under conditions of anoxia and aerobic work and is limited by reoxidation of NADH (5 1).
The basis for increased lactate in activated brain and muscle is hotly debated. Elevated lactate levels reflect a marked increase in glycolysis, which generates pyruvate faster than it can be used for mitochondrial ATP synthesis by OP; the excess pyruvate is reduced to lactate by lactate-DH under aerobic as well as hypoxic conditions. Why, then, is glycolysis increased to produce pyruvate faster than it can be used for OP? Production of pyruvate is the last of three reactions critical for ATP synthesis in the oxidoreduction-phosphorylation phase of glycolysis. The first reaction is the transfer of electrons and protons from GA311 to NAD + ; the second is synthesis of 2 ATP by SP coupled to dephosphorylation of oxidized metabolites of GA3P. Production of pyruvate is coupled to synthesis of the second ATP by pyruvate kinase. These reactions are vital for coordinating increased energy metabolism and blood flow evoked by work and for optimal ATP synthesis under aerobic and anaerobic conditions in general. However, they are limited by availability of NAD + for the first reaction (8, 5 1).
An important advantage of ATP synthesis by SP is that it can be produced ~2x as fast as by OP (8, 52) to support high rates of ATP use (as with vigorous muscle activity during a sprint to escape danger or to catch prey). In addition, ATP generated by SP is proximate to, and may be preferentially utilized by, plasma membrane-associated ATPases activated during electrical activity and work (53) (54) (55) . When lactate (rather than glucose) is the source of pyruvate for ATP synthesis by OP, no ATP is synthesized by SP (Fig.4A) The net yield of ATP per mole of glucose during aerobic glycolysis, is 2 ATP by SP and 28-30 ATP by OP (8) . The ATP yield from SP is increased 50% with glycogen-derived glucose. Rapid ATP synthesis via SP with work is limited by reoxidation of NADH to NAD + (51, 52) , inhibition, of glycolysis by lactate, and possibly by partial glycogen depletion and glucose uptake. In the longer Am, production of excess pyruvate ensures that pyruvate levels are not rate-limiting for OP, which, although slower, is far more efficient than SP.
The potential importance of ATP synthesis from SP during work is evident from data of Fox et al. (4) . If all of the ~5% increase in oxygen consumption in human visual cortex with photostimulation. were used for ATP synthesis from glucose by OP, and if all of the ~ 50% increase in glucose uptake not used for OP were metabolized to lactate, then ATP synthesis by SP would equal that by OP. With glucose derived from glycogen, the relative contribution of SP to ATP synthesis necessarily would be greater.
Chronic or frequent elevations of NADH may stimulate new vessel growth as in muscle by endurance training, in brain by neural activity and by hypoxia, and in retina by repeated lactate injections and by diabetes (14, 17, (56) (57) (58) (59) (62--64) . The impact of increased NADH on other signaling pathways and redox-sensitive transcription factors (e.g., NF-KB; nuclear transcription factor-KB), although likely, has not yet been shown.
In humans who suffer from "panic" attacks, lactate injection precipitates an attack coupled to increased regional cerebral blood flows (50) . This finding suggests that accumulation of electrons in NADH mediates panic disorder as well as increased blood flow. Carr and Sheehan (65) hypothesized that the disorder may be caused by a defect within the redox-regulating apparatus of the brain. They proposed that infusion of pyruvate together with lactate might be expected to prevent the typical lactate-induced response. This prediction has not been tested.
Accumulation of electrons in NADH may contribute to other conditions associated with abnormal neural activity (e.g., galactosemia (14, 66) , epileptic seizures,, and defects in energy metabolism). These conditions could all be potential candidates for therapies designed to transfer electrons from NADH to substrates (e.g., pyruvate) that would not perturb signaling or other metabolic pathways.
The observation that lactate injection doubled the increased blood flow in stimulated somatosensory cortex (without affecting flow in contralateral resting cortex) has implications for enhancing sensitivity of functional brain imaging. For example, injection of lactate could substantially amplify blood flows for mapping physiological neural activity in subtle tasks (67) .
Accumulation of electrons in cytosolic; free NADH is an elegantly simple multifunctional sensor of local blood-flow need. It accounts for blood-flow increases by a remarkable range of stimuli from activation of excitable membranes of muscle and brain to hyperglycemia in diabetes.
